MIPS Molecular Imaging Program at Stanford

Visiting Faculty

Cumali Aktolun

Cumali Aktolun, MD, MSc

Visiting Faculty, Multimodality Molecular Imaging Lab (MMIL)

Education:

Medical School: 1979-1985 (6 years)- Gazi University School of Medicine (First Year), Ankara, Turkey, and Gülhane Askeri Tip Akademisi, Ankara, Turkey (Following 5 Years), Ankara, Turkey
Residency and Specialty Training in Nuclear Medicine: 1987-1990 (3 years), Gülhane Askeri Tip Akademisi, Ankara, Turkey.
Master of Science (M.Sc.) in Nuclear Medicine: 1991-1993 (2 years), London University, Royal Postgraduate Medical School, Hammersmith Hospital, Department of Diagnostic Radiology, Nuclear Medicine Unit, London, U.K.
Clinical Research Fellowship in Nuclear Medicine: 1991-1996, Royal Postgraduate Medical School, Hammersmith Hospital, Department of Diagnostic Radiology, Nuclear Medicine Unit, London, U.K.


Contact Information:

Molecular Imaging Program at Stanford
James H. Clark Center
318 Campus Drive, Room E-153
Stanford, CA, 94305-5427

Phone: (650) 725-6175
E-mail: aktolun@stanford.edu


Research Interests:

Radionuclide Therapy (RIT, Radiopeptide, MIBG, Radioembolization)
Non-FDG PET/CT Imaging (Ga-68 DOTA PET/CT)
Molecular Imaging (radionuclide based techniques)


Recent Publications:

  1. Umut Elboga, Ebuzer Kalender, Y.Zeki Çelen,M., Cumali Aktolun. Axillary Lymph Node Metastasis of Papillary Thyroid Carcinoma Detected by FDG PET/CT in a Thyroglobulin Positive Patient with Negative Whole Body Iodine-131 Scan. Clin Nucl Med. 2012; 37: 1120-1122.
  2. Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A. (131)I/ (123)I-Metaiodobenzyl guanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010 ; 37 (12): 2436-46.
  3. Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-Delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A. Oncology Committee of the EANM. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010; 37: 1441-8.
  4. Demir H, Berk F, Raderer M, Plowman PN, Lassen U, Daugaard G, Clausen M, Bohuslavizki KH, Peters M, Harmer C, Malamitsi J, Aktolun C. The role of nuclear medicine in the diagnosis of cancer of unknown origin. Q J Nucl Med Mol Imaging. 2004; 48:164-73.
  5. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP140-7.
  6. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP132-9.
  7. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. 67Ga scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP125-31.
  8. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP115-24.
  9. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP107-14.
  10. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Morteímans L, Reske SN. Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003; 30: BP99-106.
  11. Berk F, Demir H, Aktolun C. Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments. Q J Nucl Med. 2003; 47:63-74.
  12. Demir H, Erbay G, Kir KM, Omurlu K, Berk F, Aktolun C. Clinical validation of technetium-99m MIBI-gated single-photon emission computed tomography (SPECT) for avoiding false positive results in patients with left bundle-branch block: comparison with stress-rest nongated SPECT. Clin Cardiol. 2003; 26:182-7.
  13. Demir H, Berk F, Isgoren S, Erdincler RO, Ciftci E, Aktolun C. Subhyoid ectopic thyroid with mediolateral location in a developmentally retarded child with hypothyroidism in an iodine deficiency region. Ann Nucl Med. 2002; 16:483-6.
  14. Berk F, Demir H, A_açdiken A, Ural D, Aktolun C. Hypertrophied papillary muscles mimicking left ventricular mass on Tc-99m MIBI myocardial perfusion scintigraphy. J Nucl Cardiol. 2002; 9: 441-2.
  15. Berk F, Demir H, Erdincler O, Isgoren S, Aktolun C. Tc-99m MDP and Tc-99m MIBI dual imaging of photopenic bone metastases of carcinoma of the larynx. Clin Nucl Med. 2002; 27:442-3.
  16. Demir H, Berk F, Memisoglu K, Arslan A, Muezzinoglu B, Erdincler RO, Isgoren S, Sarlak A, Aktolun C. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI. Ann Nucl Med. 2002;16:151-5.
  17. Berk F, Demir H, Hacihanefioglu A, Arslan A, Erdincler O, Isgoren S, Aktolun C. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images. Ann Nucl Med. 2002;16:137-41.
  18. Demir H, Berk F, Erdincler O, Isgoren S, Aktolun C. Tl-201 imaging in the diagnostic work-up of squamous cell carcinoma metastasis of unknown primary origin. Clin Nucl Med. 2002;27:385-6.
  19. Berk F, Demir H, Erdincler O, Isgoren S, Aktolun C. Ga-67 accumulation in inguinal hernia mimicking lymph nodes in non-Hodgkin's lymphoma. Clin Nucl Med. 2002;27:65-6.
  20. Aktolun C, Demir H, Berk F. Complete lingual ectopia of the thyroid in a hypothyroid child. Thyroid. 2001;11:1081.
  21. Aktolun C, Berk F, Demir H, Ercin C. Tc-99m MIBI imaging in malignant fibrous histiocytoma. Ann Nucl Med. 2001;15:451-3.
  22. Aktolun C, Demir H, Berk F, Metin Kir K. Diagnosis of complete ectopic lingual thyroid with Tc-99m pertechnetate scintigraphy. Clin Nucl Med. 2001;26:933-5.
  23. Aktolun C, Berk F, Demir H. Detection of cold bone metastasis by Tc-99m MIBI imaging. Ann Nucl Med. 2001;15:393-5.
  24. Ural D, Ural E, Kahraman G, Caymaz O, Aktolun C, Komsuolu B. Effect of the Valsalva manoeuver on diastolic filling indices in patients with essential hypertension. J Hum Hypertens. 2001;15:607-12.
  25. Aktolun C. What is the best technique for patient positioning during breast scintigraphy? J Nucl Med. 1996;37:2098-100.
  26. Aktolun C. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1995;181:477-9.
  27. Aktolun C, Bayhan H, Ozturk E. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201. Clin Nucl Med. 1995;20:446-8.
  28. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekera RD, Peters AM. Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies. Eur J Nucl Med. 1995;22:330-4.
  29. Ussov WY, Aktolun C, Myers MJ, Jamar F, Peters AM. Granulocyte margination in bone marrow: comparison with margination in the spleen and liver. Scand J Clin Lab Invest. 1995;55:87-96.
  30. Aktolun C. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging. J Nucl Med. 1994;35:2055-6.
  31. Aktolun C, Bayhan H. Tc-99m MIBI uptake in pulmonary sarcoidosis. Preliminary clinical results and comparison with Ga-67. Clin Nucl Med. 1994;19:1063-5.
  32. Aktolun C. Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med. 1994;21:1257-60.
  33. Aktolun C. Tc-99m sestamibi imaging is useful in brain metastases. Clin Nucl Med. 1994;19:1033-4.
  34. Aktolun C. TBI is not MIBI. J Nucl Med. 1994;35:1560-1.
  35. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan. Eur J Nucl Med. 1994;21:973-9.
  36. Arka A, Aktolun C, Gooden C, Epenetos A, Papadimitriou A. Tc-99m-labeled nonspecific polyclonal human immunoglobulin G is taken up by malignant tumors. Clin Nucl Med. 1994;19:708-12.
  37. Aktolun C. Misleading figure of focal activity in the liver. J Nucl Med. 1993;34:2276.
  38. Aktolun C. 201Tl as a tumour-localizing agent. Nucl Med Commun. 1993;14:1042-4.
  39. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Clin Nucl Med. 1992;17:171-6.
  40. Aktolun C, Demirel D, Kir M, Bayhan H, Maden HA. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med. 1991 Jul;32(7):1429-31.
  41. Aktolun C, Bayhan H. Detection of focal nodular hyperplasia with liver colloid single photon emission computed tomography: a case report and review of the literature. Br J Radiol. 1991;64:64-6.
  42. Aktolun C, Bayhan H, Celasun B, Kir MK. Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease). Eur J Nucl Med. 1991;18:856-9.

Stanford Medicine Resources:

Footer Links: